Skye Bioscience, Inc. (SKYE)
1.05
+0.07
(+7.08%)
USD |
NASDAQ |
Jan 22, 16:00
1.04
-0.01
(-0.95%)
After-Hours: 20:00
Skye Bioscience Free Cash Flow: -41.53M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Perspective Therapeutics, Inc. | -106.85M |
| Theravance Biopharma, Inc. | 243.48M |
| Viking Therapeutics, Inc. | -224.58M |
| Kyntra Bio, Inc. | -17.14M |
| Myomo, Inc. | -13.85M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -13.36M |
| Cash from Investing (Quarterly) | 7.967M |
| Free Cash Flow Per Share (Quarterly) | -0.3369 |
| Free Cash Flow to Equity (Quarterly) | -13.32M |
| Free Cash Flow to Firm (Quarterly) | -13.36M |
| Free Cash Flow Yield | -99.53% |